Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
-
2025
September 2023 - 40 products
L
IP
CI
Skyrizi 360 mg
2297.30
2514.85
10 %
Injektionslösung in einer Patrone für ein Dosiergerät: Risankizumabum 360mg / 2.4ml
AbbVie AG
B / SL
FB
G
IP
Skyrizi 180 mg
PR
PR
k.A.
Injektionslösung in einer Patrone für ein Dosiergerät: Risankizumabum 180mg / 1.2ml
AbbVie AG
B
FB
G
L
IP
Skyrizi 600 mg/10 ml
2297.30
2514.85
10 %
Infusionskonzentrat: Risankizumabum 600mg / 10ml
AbbVie AG
B / SL
FB
G
IP
Skyrizi 600 mg/10 ml
2
PR
PR
k.A.
Infusionskonzentrat: Risankizumabum 600mg / 10ml
AbbVie AG
B
FB
G
IP
CI
Teriflunomid-Mepha 14 mg
28
384.43
434.50
k.A.
Filmtabletten: Teriflunomidum 14 mg
Mepha Pharma AG
B
FB
G
IP
CI
Teriflunomid-Mepha 14 mg
84
1153.31
1270.70
k.A.
Filmtabletten: Teriflunomidum 14 mg
Mepha Pharma AG
B
FB
G
IP
Teriflunomid-Mepha 14 mg QOD
28
PR
PR
k.A.
Filmtabletten: Teriflunomidum 14 mg
Mepha Pharma AG
B
FB
G
L
IP
Imjudo 25 mg/1,25 ml
1428.67
1570.20
10 %
Infusionskonzentrat: Tremelimumabum 25mg / 1.25ml
AstraZeneca AG
A / SL
FB
G
L
IP
Imjudo 300 mg/15 ml
17144.04
17897.60
10 %
Infusionskonzentrat: Tremelimumabum 300mg / 15ml
AstraZeneca AG
A / SL
FB
G
IP
Elrexfio 44 mg/1.1 ml
2859.03
3125.80
10 %
Injektionslösung: Elranatamabum 44mg / 1.1ml
Pfizer AG
A / SL
FB
G
IP
Elrexfio 76 mg/1.9 ml
4938.32
5374.50
10 %
Injektionslösung: Elranatamabum 76mg / 1.9ml
Pfizer AG
A / SL
FB
G
IP
CI
Mekinist 4.7 mg
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: Trametinibum 4.7 mg
Novartis Pharma
Schweiz AG
A
FB
G
CI
CM
Rotpunkt Apotheke
Bronchialpastillen neo
36
PR
PR
k.A.
Pastillen: 6 Active Agents
Tentan AG
E
FB
G
IP
CI
Tafinlar 10 mg
210
PR
PR
k.A.
Tablette zur Herstellung einer Suspension zum Einnehmen: Dabrafenibum 10 mg
Novartis Pharma
Schweiz AG
A
FB
G
Rivaroxaban Sandoz eco
vascular 2.5 mg
10
PR
PR
k.A.
Filmtabletten: Rivaroxabanum 2.5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Rivaroxaban Sandoz eco
vascular 2.5 mg
30
PR
PR
k.A.
Filmtabletten: Rivaroxabanum 2.5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Rivaroxaban Sandoz eco
vascular 2.5 mg
56
PR
PR
k.A.
Filmtabletten: Rivaroxabanum 2.5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Rivaroxaban Sandoz eco
vascular 2.5 mg
100
PR
PR
k.A.
Filmtabletten: Rivaroxabanum 2.5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Rivaroxaban Sandoz eco
vascular 2.5 mg
196
PR
PR
k.A.
Filmtabletten: Rivaroxabanum 2.5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
CI
Wala Aconit comp.
Schmerzöl
50 ml
PR
PR
k.A.
WALA Schweiz AG
D
FB
G
L
IP
V/S
Atgam 250 mg/5 ml
5 x 5 ml
2797.16
3058.50
10 %
Infusionskonzentrat: Immunoglobulinum Anti-T Limphocytorum ex Equus 50 mg
Pfizer AG
A / SL
FB
G
IP
CI
Elymbus 0.1 mg/g
30 x 0.3 g
15.87
33.70
10 %
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Elymbus 0.1 mg/g
90 x 0.3 g
45.23
65.60
10 %
THEA Pharma S.A.
B / SL
FB
G
IP
CI
Mebucaïne Dolo Spray 8.75 mg
15 ml
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Flurbiprofenum 17.16 mg/ml
Spirig HealthCare AG
D
FB
G
IP
CI
Irfen Dolo liquid caps 400 mg
10
PR
PR
k.A.
Weichkapseln: Ibuprofenum 400 mg
Mepha Pharma AG
D
FB
G
IP
Cyclolux
10 ml
27.28
46.10
10 %
Injektionslösung: Acidum Gadotericum 279.32 mg/ml
b.e.imaging.ag
B / SL / SG
FB
G
IP
Cyclolux
15 ml
37.07
56.75
10 %
Injektionslösung: Acidum Gadotericum 279.32 mg/ml
b.e.imaging.ag
B / SL / SG
FB
G
IP
Cyclolux
20 ml
46.85
67.35
10 %
Injektionslösung: Acidum Gadotericum 279.32 mg/ml
b.e.imaging.ag
B / SL / SG
FB
G
L
IP
Cyclolux
60 ml
130.97
158.20
10 %
Injektionslösung: Acidum Gadotericum 279.32 mg/ml
b.e.imaging.ag
B / SL / SG
FB
G
L
IP
Cyclolux
100 ml
218.28
253.80
10 %
Injektionslösung: Acidum Gadotericum 279.32 mg/ml
b.e.imaging.ag
B / SL / SG
FB
G
L
IP
CI
Ibrance 75 mg
21
1973.56
2162.80
10 %
Filmtabletten: Palbociclibum 75 mg
Pfizer AG
A / SL
FB
G
L
IP
Ibrance 100 mg
21
1973.56
2162.80
10 %
Filmtabletten: Palbociclibum 100 mg
Pfizer AG
A / SL
FB
G
L
IP
Ibrance 125 mg
21
1973.56
2162.80
10 %
Filmtabletten: Palbociclibum 125 mg
Pfizer AG
A / SL
FB
G
L
IP
Azacitidin Stada 100 mg
218.38
253.90
10 %
Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Azacitidin Stada 150 mg
304.64
347.75
10 %
Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 150 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
Sugammadex Labatec 200
mg/2ml
10
PR
PR
k.A.
Injektionslösung: Sugammadexum 200mg / 2ml
Labatec Pharma SA
B
FB
G
IP
Sugammadex Labatec 500
mg/5ml
10
PR
PR
k.A.
Injektionslösung: Sugammadexum 500mg / 5ml
Labatec Pharma SA
B
FB
G
IP
Elfabrio 20 mg/10 ml
1864.18
2043.80
10 %
Infusionskonzentrat: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A / SL
FB
G
IP
Elfabrio 20 mg/10 ml
5
PR
PR
k.A.
Infusionskonzentrat: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A
FB
G
IP
Elfabrio 20 mg/10 ml
10
PR
PR
k.A.
Infusionskonzentrat: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home